The Pros and Cons of Different CDMO Models

The pharmaceutical industry has come to rely on Contract Development and Manufacturing Organizations (CDMOs) for drug development and commercialization, using a variety of business models for different advantages. These include the Boutique, Large, End-to-End, Fee-for-Service, Licensing, and Front-Loaded models. Each model has its own benefits and drawbacks, and selecting the right one requires careful consideration of project’s needs and the company’s goals.